Discover 754 paid clinical trials in Toledo, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 754
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
for
Relapsed or Refractory T Cell Lymphoma
Location: Detroit MI, Cleveland OH, Buffalo NY, St Louis MO,
Sponsor: Ono Pharmaceutical Co. Ltd
Sex: All
Age: 18+
Code: NCT05079282
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: Detroit MI, Cleveland OH, Grand Rapids MI, Fairfax VA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07205718
Phase1, Phase2, Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
for
Melanoma (Skin Cancer),
Location: Detroit MI, Cincinnati OH, Madison WI, Fairfax VA,
Sponsor: Aminex Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07287917
Phase1, Phase2, Recruiting
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
for
Chronic Graft-versus-host-disease
Location: Detroit MI, Columbus OH, Pittsburgh PA, Chicago IL,
Sponsor: Syndax Pharmaceuticals
Sex: All
Age: 2+
Code: NCT04710576
Phase2, Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Detroit MI, Canton OH, Dayton OH, Cincinnati OH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07518186
Phase3, Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Detroit MI, Farmington Hills MI, Marion OH,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase3, Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Detroit MI, Fort Wayne IN, Cleveland OH,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361497
Phase3, Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
for
Follicular Lymphoma (FL)
Location: Detroit MI, Cleveland OH, Noblesville IN,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06091254
Phase3, Recruiting
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
for
Relapsed/Refractory Small Cell Lung Cancer
Location: Detroit MI, Cleveland OH, Buffalo NY, Nashville TN,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07325136
Phase1, Phase2, Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
for
Chronic Lymphocytic Leukemia (CLL),
Location: Detroit MI, Fort Wayne IN, Cleveland OH, Columbus OH,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07221500
Phase2, Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
for
Urothelial Cancer
Location: Detroit MI, Cleveland OH, Mayfield Heights OH,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07106762
Phase2, Phase3, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Detroit MI, Cleveland OH, Kalamazoo MI, Hilliard OH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213804
Phase3, Recruiting
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Detroit MI, Cleveland OH, Cincinnati OH, Durham NC,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06859762
Phase1, Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Detroit MI, Dayton OH, Chicago IL, Rochester NY,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase3, Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for
Prostate Cancer
Location: Detroit MI, Gahanna OH, Cincinnati OH, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06855277
Phase3, Recruiting
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Location: Detroit MI, Columbus OH, Rochester MN, New York NY,